Latest News

  • Review shows: EGb 761® optimizes standards of life for tinnitus patients!

    Read more


Euvegal® - WS® 1014, WS® 1303

for restlessness and sleep-induction disturbances due to nervous conditions

Active ingredient:

Dry extract from Valerian root WS® 1014 and dry extract from Melissa leaves WS® 1303

Approximately 20 – 30 % of the patients consulting a general practitioner report on nervous unrest and sleep disturbances such as insomnia. Common triggers of these conditions include everyday issues such as school- or job pressure, family or marital problems. The use of synthetic tranquillizers and sedatives is widespread, but may include the risk of significant side effects.

Euvegal® contains the standardised dry extracts WS® 1014 from valerian root and WS® 1303 from melissa leaves and is a clinically proven treatment for restlessness and sleep disturbances. It improves sleep quality and well-being during the day and has an excellent tolerability without the risk of hang-overs or addiction. Euvegal® has no negative influence on concentration and mental performance.

Approved indication in Germany:

Restlessness; sleep-induction disturbances due to nervous conditions

Note: If conditions persist, are unclear or new, consult a doctor as diseases requiring medical clarification might be involved.

For information on precautions for use, side effects and contra-indications see the package leaflet or contact your doctor or pharmacist.

Data based on information issued 2008/05